Magnolol is the major neolignan of Magnolia officinalis bark — the "houpu" of Chinese pharmacopoeia, used for over two thousand years to ease nervous tension. It is today one of the few plant compounds whose GABAergic mechanism is precisely characterised.
The scientific mechanism Magnolol acts as a positive allosteric modulator of GABA-A receptors, the central nervous system's main brake. Key point: it binds at a site distinct from the benzodiazepine site. It therefore amplifies the GABA your brain already produces rather than forcing sedation. That explains the felt profile — a calm that settles into the body, without next-day fog. The literature also documents antioxidant and anti-inflammatory action on nervous tissue.
What the data says — and what it does not Most Magnolol research is preclinical (animal models): anxiolysis, sleep architecture, sleep onset latency. Human data mostly covers standardised magnolia bark extracts, not isolated Magnolol. We prefer to state it plainly: a molecule with a solid mechanism and a long traditional record, but not a sleeping pill and not a replacement for any treatment.
Quality & Transparency Commitment Isolated Magnolol, HPLC purity >98%, dosed at 400 mg per capsule. Single-ingredient — no diluted extract, no "proprietary" blend hiding real doses. HPMC vegetal capsule, no fillers, no magnesium stearate.
